Cholesterol clinical trials at UCSF

2 in progress, 1 open to eligible people

Cholesterol is a substance found in your body used for building cells. UCSF is studying inclisiran's effectiveness and safety in children with high cholesterol conditions. These trials focus on how well the treatment works and its potential side effects.

Showing trials for

  • Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

    open to eligible people ages 6-11

    This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 6 to <12 years) with heterozygous familial hypercholesterolemia (HeFH) and elevated low density lipoprotein cholesterol (LDLC).

    San Francisco, California and other locations

  • Inclisiran in Children With Homozygous Familial Hypercholesterolemia

    Sorry, not currently recruiting here

    This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 2 to <12 years) with homozygous familial hypercholesterolemia (HoFH) and elevated low density lipoprotein cholesterol (LDLC).

    San Francisco, California and other locations

Our lead scientists for Cholesterol research studies include .

Last updated: